Evidence map›Paper›PMID 30669143›Full record

Observational studyAmerican journal of nephrology2019

Cortical Perfusion and Tubular Function as Evaluated by Magnetic Resonance Imaging Correlates with Annual Loss in Renal Function in Moderate Chronic Kidney Disease.

Pottumarthi V Prasad, Lu-Ping Li, Jon M Thacker, Wei Li, Bradley Hack, Orly Kohn, Stuart M Sprague

Registry-linked trialOpen access · bronzeAbstract readObservational Study
In one paragraph

Observational study in American journal of nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07175051 (Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin), which is not on this map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07175051 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

TypeinterventionalSponsorUniversity of Illinois at ChicagoRan2026 to 2030Enrolled20ConditionsSickle Cell Anemia (HbSS, or HbSβ-thalassemia0), AlbuminuriaArmsEmpagliflozin (oral)
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2021
    Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pottumarthi V PrasadDepartment of Radiology, NorthShore University HealthSystem, Evanston, Illinois, USA, pprasad@northshore.org.
Lu-Ping LiDepartment of Radiology, NorthShore University HealthSystem, Evanston, Illinois, USA.
Jon M ThackerDepartment of Radiology, NorthShore University HealthSystem, Evanston, Illinois, USA.
Wei LiDepartment of Radiology, NorthShore University HealthSystem, Evanston, Illinois, USA.
Bradley HackDepartment of Radiology, NorthShore University HealthSystem, Evanston, Illinois, USA.
Orly KohnPritzker School of Medicine, University of Chicago, Chicago, Illinois, USA.
Stuart M SpraguePritzker School of Medicine, University of Chicago, Chicago, Illinois, USA.
NorthShore University HealthSystem · USUniversity of Chicago · US

Funding

Longitudinal changes in the intra-renal oxygenation by BOLD MRI in patients withR01DK093793 · NIDDK · ENDEAVOR HEALTH CLINICAL OPERATIONS · PI PRASAD, POTTUMARTHI V · 2012 to 2016
$2.3M
The Intra-renal Oxygenation in CKD as evaluated by BOLD MRIR21DK079080 · NIDDK · ENDEAVOR HEALTH CLINICAL OPERATIONS · PI PRASAD, POTTUMARTHI V · 2009 to 2010
$431k
Quantitative renal oxygenation assessment with compartment specific calibrationF31HL123360 · NHLBI · NORTHWESTERN UNIVERSITY · PI THACKER, JON MATTHEW · 2015 to 2016
$70k
NHLBI NIH HHS F31 HL123360NIDDK NIH HHS R01 DK093793NIDDK NIH HHS R21 DK079080
6 · The paper itself

Abstract

backgroundChronic hypoxia is a well-recognized factor in the pathogenesis of chronic kidney disease (CKD). Loss of microcirculation is thought to lead to enhanced renal hypoxia, which in turn results in the development of fibrosis, a hallmark of progressive CKD. To evaluate the role of functional magnetic resonance imaging (MRI), we performed perfusion, oxygenation, and diffusion MRI measurements in individuals with diabetes and stage 3 CKD.

methodsFifty-four subjects (41 individuals with diabetes and stage 3 CKD and 13 healthy controls) participated in this study. Data with blood oxygenation level dependent (BOLD), arterial spin labeling perfusion and diffusion MRI were acquired using a 3T scanner.

resultsRenal cortical perfusion was reduced in CKD compared to the controls (109.54 ± 25.38 vs. 203.17 ± 27.47 mL/min/100 g; p < 0.001). Cortical apparent diffusion coefficient showed no significant reduction in CKD compared to controls (1,596.10 ± 196.64 vs. 1,668.72 ± 77.29 × 10-6 mm2/s; p = 0.45) but was significantly associated with perfusion. Cortical R2* values were modestly increased in CKD (20.76 ± 4.08 vs. 18.74 ± 2.37 s-1; p = 0.12). Within the CKD group, R2*_Medulla and R2*_Kidney were moderately and negatively associated with estimated glomerular filtration rate. There was a significant association between cortical perfusion and medullary response to furosemide with annual loss of renal function, used as an estimate of CKD progression.

conclusionsSubjects with a moderate degree of CKD had significantly lower renal perfusion. Diffusion and BOLD MRI showed more modest differences between the groups. Individuals with progressive CKD had lower perfusion and response to furosemide.

Indexed as

AgedCell HypoxiaDiffusion Magnetic Resonance ImagingDisease ProgressionFemaleFurosemideGlomerular Filtration RateHumansKidney CortexKidney TubulesMagnetic Resonance AngiographyMaleMiddle AgedOxygenOxygen ConsumptionRenal Insufficiency, ChronicFurosemideOxygenChronic kidney diseaseDiabetesFibrosisMagnetic resonance imagingOxygenationPerfusion

Identifiers

PMID30669143
PMCPMC6387452
OpenAlexW2911463344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.